Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: A multicentre randomised controlled trial

The Lancet

Volumn 380, Issue 9857, 2012, Pages 1927-1935

  Pickard, Robert ^a   Lam, Thomas ^b   MacLennan, Graeme ^c   Starr, Kath ^b,c   Kilonzo, Mary ^b   McPherson, Gladys ^c   Gillies, Katie ^c   McDonald, Alison ^c   Walton, Katherine ^d   Buckley, Brian ^e,f   Glazener, Cathryn ^c   Boachie, Charles ^c   Burr, Jennifer ^c   Norrie, John ^c   Vale, Luke ^a   Grant, Adrian ^b   N'Dow, James ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^f UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; CORTICOSTEROID; METHOTREXATE; NITROFURAL; POLITEF; SILVER;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLADDER CATHETERIZATION; CATHETER INFECTION; CONTROL GROUP; CONTROLLED STUDY; DEVICE INFECTION; FEMALE; HOSPITAL PERSONNEL; HUMAN; INCIDENCE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; UNITED KINGDOM; URINARY TRACT INFECTION; URINE CULTURE;

EID: 84870290121     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61380-4     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. Preventing healthcare-associated infections. http://www.cdc.gov/HAI/prevent/prevention.html (accessed Dec 19, 2011).
2. Centers for Disease Control and Prevention. National Hospital Discharge Survey: 2009 table, number and rate of hospital discharges. http://www.cdc.gov/ nchs/data/nhds/1general/2009gen1-agesexalos.pdf (accessed April 17, 2012).
3. Centers for Disease Control and Prevention. NHSN Annual Reports. http://www.cdc.gov/nhsn/PDFs/dataStat/NHSN-Report-2010-Data-Summary.pdf (accessed March 20, 2012).
4. Mendoza MT, Billote-Domingo K, Torres TT. Catheter-related urinary tract infections: incidence, risk factors and microbiologic profile. Philipp J Microbiol Infect Dis 1999; 28: 133-38.
5. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32: 101-14.
6. The burden of endemic health care-associated infection worldwide. World Health Organisation report 2011. http://whqlibdoc.who.int/ publications/2011/ 9789241501507-eng.pdf (accessed July 4, 2012).
7. Pratt RJ, Pellowe CM, Wilson JA, et al. EPIC2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007; 65 (suppl 1): S1-64.
8. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA, Healthcare Infection Control Practices Advisory Committee. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010; 31: 319-26.
9. Burton DC, Edwards JR, Srinivasan A, Fridkin SK, Gould CV. Trends in catheter-associated urinary tract infections in adult intensive care unit-United States, 1990-2007. Infect Control Hosp Epidemiol 2011; 32: 748-56.
10. Johnson JR, Delavari P, Azar M. Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection. Antimicrob Agents Chemother 1999; 43: 2990-95.
11. Schumm K, Lam TB. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev 2008; 2: CD004013.
12. N'Dow J. 05/46/01: The CATHETER trial: types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation (ISCRTN 75198618). http://www.hta.ac.uk/1536 (accessed May 5, 2012).
13. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16: 199-208.
14. Kind P, Hardman G, Macran S. UK population norms for EQ-5D. http://www.york.ac.uk/media/che/documents/papers/discussionpapers/ CHE%20Discussion%20Paper%20172.pdf (accessed July 17, 2011).
15. Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000; 160: 3294-98.
16. Plowman R, Graves N, Esquivel J, Roberts JA. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. J Hosp Infect 2001; 48: 33-42. (Pubitemid 32631882)
17. Rupp ME, Fitzgerald T, Marion N, et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control 2004; 32: 445-50. (Pubitemid 39574468)
18. HCAI Technology Innovation Programme. Showcase hospitals report number 1: Bardex I.C. silver alloy and hydrogel-coated catheter. http://hcai.dh.gov.uk/ files/2011/03/090616-HCAI-Technology-Innovation-Programme-Showcase-Hospitals- Report-1-Bardex-IC.pdf (accessed July 5, 2011).
19. Seymour C. Audit of catheter-associated UTI using silver alloy-coated Foley catheters. Br J Nurs 2006; 15: 598-603.
20. Healthcare Infection Control Practices Advisory Committee. CAUTI appendices. http://www.cdc.gov/hicpac/cauti/001-cauti.html (accessed Oct 12, 2011).
21. Curtis J, Perry K. CEP06001: evidence review: Bardex IC Foley Catheter. http://nhscep.useconnect.co.uk/CEPProducts/Catalogue.aspx (accessed Oct 12, 2011).
22. Healthcare Infection Control Practices Advisory Committee. Guideline for prevention of catheter-associated urinary tract infections. http://www.cdc.gov/ hicpac/pdf/CAUTI/ CAUTIguideline2009final.pdf (accessed July 5, 2011).
23. LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997; 337: 536-42. (Pubitemid 27352021)
24. Stensballe J, Tvede M, Looms D, et al. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann Intern Med 2007; 147: 285-93. (Pubitemid 351664555)
25. Guay DR. An update on the role of nitrofurans in the management of urinary tract infections. Drugs 2001; 61: 353-64. (Pubitemid 32270044)
26. Tiwari MM, Charlton ME, Anderson JR, Hermsen ED, Rupp ME. Inappropriate use of urinary catheters: A prospective observational study. Am J Infect Control 2012; 40: 51-54.
27. US Department of Health and Human Services (HHS). Action plan to prevent healthcare-associated infections: executive summary. http://www.hhs.gov/ash/ initiatives/hai/exsummary.html (accessed Dec 12, 2011).